资讯

Medical Dialogues3 小时
Bayer Jivi gets USFDA approval for pediatric patients 7 years of age and older with ...
Whippany: Bayer announced that the U.S. Food and Drug Administration (FDA) has approved Jivi, a recombinant DNA-derived, ...
Hemophilia News Today21 小时
Jivi approved by FDA for children with hemophilia A as young as 7
The FDA has extended its approval of Jivi to cover the therapy's use in children with hemophilia A ages 7 years and older.